PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Tower Cold Chain launches KTEvolution container for pharmaceutical transport

The temperature-controlled transportation of pharmaceuticals, life-science and biotech products is now even easier thanks to the latest launch from Tower Cold Chain ...
Continue Reading →
News

Sanofi and IGM Biosciences team up to develop antibody agonists

Collaboration will involve the development of new class IgM antibodies with a view to gaining market approval Sanofi and IGM have announced the signing of a colla...
Continue Reading →
News

Stalicla completes phase 1b trials into precision medicine for autism spectrum disorder

STP1 has demonstrated good safety and tolerability profiles, while also showing positive results for neurological function Swiss clinical-stage biotech company, S...
Continue Reading →
News

FDA rejects Eli Lilly lung cancer med

Eli Lilly & Co’s lung cancer hopeful, sintilimab, got hit with a complete response letter from the U.S. FDA. The agency says it needs more information ...
Continue Reading →
News

Eagle Pharmaceuticals to buy Acacia Pharma

Cambridge, UK-based Acacia Pharma has agreed to a takeover from Eagle Pharmaceuticals that values the company at around $104 million. As part of the transaction, ...
Continue Reading →
News

Sanofi wins first place in ASMD treatment race

Sanofi now has the “only approved treatment for ASMD,” after Japan’s drug regulator cleared Zenpozyme for use in patients of all ages. Also known as olipudase alf...
Continue Reading →
News

Biogen, Ionis ALS drug flops in trials

Biogen and Ionis Pharmaceuticals were hoping to be the first to find a cure for ALS. That dream has now fizzled out with the companies calling it quits after re...
Continue Reading →
News

AstraZeneca, Chugai reach patent dispute settlement

AstraZeneca’s rare disease group, Alexion, and Roche’s Chugai Pharmaceutical unit are putting down their weapons. The two have reached a settlement agreement...
Continue Reading →
News

Pfizer to supply UNICEF up to 4 million treatment courses of novel COVID-19 oral treatment for low- and middle-income countries

Pfizer Inc. (NYSE: PFE) announced today an agreement with UNICEF to supply up to 4 million treatment courses of its COVID-19 oral treatment, PAXLOVID™ (nirmatrelvir ...
Continue Reading →
News

Takeda’s Exkivity receives MHRA conditional marketing authorisation

Approval of Exkivity could mean NHS access to ground-breaking treatment for patients with rare lung cancer The Medicines and Healthcare products Regulatory Agency...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026